Blackstone Inc
APLS

Blackstone Inc’s Apellis Pharmaceuticals APLS Stock Holding History

Blackstone Inc’s Portfolio APLS Stock Details APLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-12,712
Closed -$511K – 528
2026
Q1 		$511K Buy
+12,712
New +$274K ﹤0.01% 294

Other funds holding APLS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Blackstone Inc's APLS Position: Q2 2026 in Review

Blackstone Inc sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 12,712 shares — an estimated $511K sold.

Blackstone Inc first reported a position in APLS in Q1 2026 and held it in 1 quarter. The position peaked at $511K in Q1 2026. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

  • Blackstone Inc reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Blackstone Inc sold 12,712 Apellis Pharmaceuticals shares in Q2 2026, an estimated $511K.
  • Blackstone Inc first reported a position in Apellis Pharmaceuticals in Q1 2026 and held it in 1 quarter.
  • Blackstone Inc's Apellis Pharmaceuticals position peaked at $511K in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on Blackstone Inc's 13F filing for Q2 2026, filed 14 Aug 2026.